phrykt

West Pharmaceutical Services (WST) debt: $203M

West Pharmaceutical Services had $203M of long-term debt on Dec 31, 2025, including the part due within a year, up 0.1% from $203M a year earlier.

From West Pharmaceutical Services's filings with the SEC · Read the filing · WST stock page

West Pharmaceutical Services debt by year

$253M2021$209M2022$207M2023$203M2024$203M2025

#1,407 of 2,129 US companies by debt · See the full ranking

Year endedDebtChange
Dec 31, 2025$203M+0%
Dec 31, 2024$203M-2%
Dec 31, 2023$207M-1%
Dec 31, 2022$209M-17%
Dec 31, 2021$253M–

Debt of similar companies

Companies in the same industry as West Pharmaceutical Services, by SEC industry code, with the closest debt. Each name opens the same page for that company.

CompanyDebt, latest yearYear ended
Tandem Diabetes Care$310MDec 31, 2025
Bioventus$294MDec 31, 2025
Artivion$215MDec 31, 2025
West Pharmaceutical Services$203MDec 31, 2025
NovoCure$195MDec 31, 2025
Ufp Technologies$135MDec 31, 2025
Orthopediatrics$106MDec 31, 2025

Questions and answers

What is West Pharmaceutical Services's debt?

West Pharmaceutical Services had $203M of long-term debt on Dec 31, 2025, including the part due within a year, up 0.1% from $203M a year earlier.

Numbers as reported in West Pharmaceutical Services's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology